Mahalo | $2,600,000 | (Jun 26, 2025)
Elfie | $12,000,000 | (Jun 26, 2025)
AllSpice.io | $15,000,000 | (Jun 26, 2025)
Certified by Founder
Lodge
Neuron23
start up
United States
- South San Francisco, California
- 26/06/2025
- Series D
- $96,500,000
Neuron23™ Inc. is a leading clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The Company’s focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Founded in 2018, Neuron23 has assembled a world-class team of experts and entrepreneurs located in South San Francisco, CA.
- Industry Biotechnology Research
- Website https://neuron23.com/
- LinkedIn https://www.linkedin.com/company/neuron23-inc/
Pro Athlete Community (PAC) | $7,600,000 | (Jun 26, 2025)
Kalshi | $185,000,000 | (Jun 26, 2025)
Armory | $1,511,654 | (Jun 26, 2025)
Obviant | $7,100,000 | (Jun 26, 2025)
Qunnect | $10,000,000 | (Jun 26, 2025)
Digital Asset | $135,000,000 | (Jun 25, 2025)
Waltz | $50,000,000 | (Jun 25, 2025)
Blank Metal | $3,000,000 | (Jun 25, 2025)